Article Text

Emerging Diseases
Serological ELISA for SBV currently being evaluated

Statistics from

RECENT developments in the disease situation surrounding Schmallenberg virus (SBV) in northern Europe are discussed in the latest outbreak assessment from the International Disease Monitoring (IDM) team at Defra.

In the assessment, which was published on April 23, the IDM team says that AHVLA laboratories are currently validating a serological ELISA that has become commercially available in Europe. Defra is considering how the test could be used for surveillance and whether there is a potential …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.